Satisfying patient expectations with soft-tissue augmentation

Dermatology Online Journal

Volumn 15, Issue 7, 2009, Pages

  Mandy, Stephen H ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; HYDROXYAPATITE; POLYLACTIC ACID; BIOMATERIAL; COLLAGEN; LACTIC ACID; POLYMER;

AGE; ESTHETIC SURGERY; ESTHETICS; EXPECTATION; HUMAN; MOTIVATION; PATIENT DECISION MAKING; PATIENT SAFETY; PATIENT SATISFACTION; REVIEW; RISK ASSESSMENT; SOFT TISSUE; TREATMENT INDICATION; WRINKLE; ADIPOSE TISSUE; ADULT; ANIMAL; AUTOTRANSPLANTATION; CUTANEOUS PARAMETERS; FEMALE; INTRADERMAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; MOUSE; PSYCHOLOGICAL ASPECT; RAT; REJUVENATION; TRANSPLANTATION;

ADIPOSE TISSUE; ADULT; ANIMALS; BIOCOMPATIBLE MATERIALS; COLLAGEN; COSMETIC TECHNIQUES; DURAPATITE; ESTHETICS; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRADERMAL; LACTIC ACID; MALE; MICE; MIDDLE AGED; MOTIVATION; PATIENT SATISFACTION; POLYMERS; RATS; REJUVENATION; SKIN AGING; TRANSPLANTATION, AUTOLOGOUS;

EID: 69049089965     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. 2008 Cosmetic Surgery National Data Bank Statistics. The American Society for Aesthetic Plastic Surgery; 2009.
2. Baumann L, Replacing dermal constituents lost through aging with dermal fillers. Semin Cutan Med Surg. 2004; 23:160-166. [PubMed] (Pubitemid 39458103)
3. Lindqvist C, Tveten S, Bondevik BE et al., A randomized, evaluator-blind, multicenter comparison of the efficacy and tolerability of Perlane versus Zyplast in the correction of nasolabial folds. Plast Reconstr Surg. 2005; 115:282-289. [PubMed] (Pubitemid 40187829)
4. Lupo MP, Smith SR, Thomas JA et al., Effectiveness of Juvederm Ultra Plus dermal filler in the treatment of severe nasolabial folds. Plast Reconstr Surg. 2008; 121:289-297. [PubMed]
5. Smith S, Busso M, McClaren M et al., A Randomized, Bilateral, Prospective Comparison of Calcium Hydroxylapatite Microspheres versus Human-Based Collagen for the Correction of Nasolabial Folds. Dermatol Surg. 2007; 33:S112-S121. (Pubitemid 350233446)
6. Valantin MA, Aubron-Olivier C, Ghosn J et al., Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS. 2003; 17:2471-2477. [PubMed] (Pubitemid 38393319)
7. Fagien S, Cox SE, Finn JC et al., Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a doubleblind, randomized, placebo-controlled study. Dermatol Surg. 2007; 33:S2-S9. [PubMed] (Pubitemid 46051393)
8. American Society of Plastic Surgeons. Perception of the injection - American women's perception of cosmetic facial injectables. A Harris Interactive Survey. 2006 Dec.
9. Grammer K, Fink B, Moller AP et al., Darwinian aesthetics: sexual selection and the biology of beauty. Biol Rev Camb Philos Soc. 2003; 78:385-407. [PubMed] (Pubitemid 37193392)
10. Bashour M, History and current concepts in the analysis of facial attractiveness. Plast Reconstr Surg. 2006; 118:741-756. (Pubitemid 44318936)
11. Cam A, Siegfried WD, Pearce L, Forced attention to specific applicant qualifications: Impact on physical attractiveness and sex of applicant biases. Pers Psychol. 1981; 34:65.
12. Dipboye RL, Fromkin HL, Relative importance of applicant sex, attractiveness, and scholastic standing in evaluation of job applicant resumes. J Appl Psychol. 1975; 60:39-43.
13. Gilmore DC, Beehr TA, Love KG, Effects of applicant sex: Applicant physical attractiveness, type of rater and type of job on interview decisions. J Occup Psychol. 1986; 59:103-109.
14. Quereshi MY, Kay JP, Physical attractiveness, age, and sex as determinants of reactions to resumes. Soc Behav Pers. 1986; 14:103.
15. Morrow PC, McElroy JC, Stamper BG, The effects of physical attractiveness and other demographic characteristics an promotion decisions. J Manag. 1990; 16:723-736.
16. Frieze IH, Olson JE, Russell J, Attractiveness and income for men and women in management. J Appl Soc Psychol. 1991; 21:1039-1057.
17. Roszell P, Kennedy DEG, Physical attractiveness and income attainment among Canadians. J Psychol. 2008; 123:547-559.
18. Mandy SH, Fillers that work by fibroplasia: Poly-L-Lactic Acid. In: Carruthers J, Carruthers A, editors. Soft Tissue Augmentation. 2nd ed. Saunders; 2007. p. 101-104
19. Donath AS, Glasgold RA, Glasgold MJ, Volume loss versus gravity: new concepts in facial aging. Curr Opin Otolaryngol Head Neck Surg. 2007; 15:238-243. [PubMed]
20. Donofrio LM, Fat distribution: a morphologic study of the aging face. Dermatol Surg. 2000; 26:1107-1112. [PubMed]
21. Shaw RB, Jr., Kahn DM, Aging of the midface bony elements: a three-dimensional computed tomographic study. Plast Reconstr Surg. 2007; 119:675-681. [PubMed]
22. Rohrich RJ, Pessa JE, The fat compartments of the face: anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg. 2007; 119:2219-2227. [PubMed]
23. Pessa JE, Zadoo VP, Yuan C et al., Concertina effect and facial aging: nonlinear aspects of youthfulness and skeletal remodeling, and why, perhaps, infants have jowls. Plast Reconstr Surg. 1999; 103:635-644. [PubMed] (Pubitemid 29071582)
24. Vleggaar D, Fitzgerald R, Dermatological implications of skeletal aging: a focus on supraperiosteal volumization for perioral rejuvenation. J Drugs Dermatol. 2008; 7:209-220. [PubMed]
25. Rendon MI, Effron C, Edison BL, The use of fillers and botulinum toxin type A in combination with superficial glycolic acid (alpha-hydroxy acid) peels: optimizing injection therapy with the skin-smoothing properties of peels. Cutis. 2007; 79:9-12. [PubMed]
26. Broder KW, Cohen SR, An overview of permanent and semipermanent fillers. Plast Reconstr Surg. 2006; 118:7S-14S. [PubMed]
27. Goldman MP, Alster TS, Weiss R, A randomized trial to determine the influence of laser therapy, monopolar radiofrequency treatment, and intense pulsed light therapy administered immediately after hyaluronic acid gel implantation. Dermatol Surg. 2007; 33:535-542. [PubMed] (Pubitemid 46650363)
28. Bosniak S, Cantisano-Zilkha M, Purewal BK et al., Combination therapies in oculofacial rejuvenation. Orbit. 2006; 25:319-326. [PubMed]
29. Vleggaar D, Facial volumetric correction with injectable poly- L-lactic acid. Dermatol Surg. 2005; 31:1511-1517. [PubMed]
30. De Boulle KL, Botulinum neurotoxin type A in facial aesthetics. Expert Opin Pharmacother. 2007; 8:1059-1072. [PubMed]
31. Said S, Meshkinpour A, Carruthers A et al., Botulinum toxin A: its expanding role in dermatology and esthetics. Am J Clin Dermatol. 2003; 4:609-616. [PubMed] (Pubitemid 37108420)
32. Narins RS, Brandt FS, Lorenc ZP et al., Twelve-month persistency of a novel ribose-cross-linked collagen dermal filler. Dermatol Surg. 2008; 34 Suppl 1:S31-S39. [PubMed]
33. Baumann L, Kaufman J, Saghari S, Collagen fillers. Dermatol Ther. 2006; 19:134-140. [PubMed]
34. Narins RS, Bowman PH, Injectable skin fillers. Clin Plast Surg. 2005; 32:151-162. [PubMed]
35. Monheit GD, Coleman KM, Hyaluronic acid fillers. Dermatol Ther. 2006; 19:141-150. [PubMed]
36. Carruthers J, Carruthers A, Hyaluronic acid gel in skin rejuvenation. J Drugs Dermatol. 2006; 5:959-964. [PubMed]
37. Narins RS, Brandt F, Leyden J et al., A randomized, doubleblind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003; 29:588-595. [PubMed] (Pubitemid 36702442)
38. Lupo MP, Hyaluronic acid fillers in facial rejuvenation. Semin Cutan Med Surg. 2006; 25:122-126. [PubMed]
39. Juvéderm Ultra Plus [package insert], Santa Barbara, CA: Allergan, Inc. 2008.
40. Lowe NJ, Maxwell CA, Patnaik R, Adverse reactions to dermal fillers: review. Dermatol Surg. 2005; 31:1616-1625. [PubMed]
41. Burgess CM, Principles of soft tissue augmentation for the aging face. Clin Interv Aging. 2006; 1:349-355. [PubMed]
42. Kaufman MR, Miller TA, Huang C et al., Autologous fat transfer for facial recontouring: is there science behind the art? Plast Reconstr Surg. 2007; 119:2287-2296. [PubMed]
43. Bucky LP, Kanchwala SK, The role of autologous fat and alternative fillers in the aging face. Plast Reconstr Surg. 2007; 120:89S-97S. [PubMed]
44. Schweiger ES, Riddle CC, Wernli BJ et al., Comparison of poly-l-lactic acid and calcium hydroxylapatite for treating human immunodeficiency virus-associated facial lipoatrophy. Cosmet Dermatol. 2007; 20:304-312.
45. Johl SS, Burgett RA, Dermal filler agents: a practical review. Curr Opin Ophthalmol. 2006; 17:471-479. [PubMed]
46. Marmur ES, Phelps R, Goldberg DJ, Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler. J Cosmet Laser Ther. 2004; 6:223-226. [PubMed] (Pubitemid 40547028)
47. Radiesse Injectable implant [package insert], Franksville, WI: BioForm Medical Inc. 2006.
48. Lemperle G, Morhenn V, Charrier U, Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg. 2003; 27:354-366. [PubMed] (Pubitemid 38365030)
49. Sculptra [prescribing information], Bridgewater, NJ: Dermik Laboratories; a business of sanofi-aventis U.S. LLC. 2006.
50. Bos RRM, Rozema FR, Boering G et al., Degradation of and tissue reaction to biodegradable poly(L-lactide) for use as internal fixation of fractures: a study in rats. Biomaterials. 1991; 12:32-36. [PubMed]
51. Gogolewski S, Jovanovic M, Perren SM et al., Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3- hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res. 1993; 27:1135-1148. [PubMed] (Pubitemid 23241077)
52. Sadick NS, Poly-l-lactic acid: a perspective from my practice. J Cosmet Dermatol. 2008; 7:55-60. [PubMed]
53. Woerle B, Hanke CW, Sattler G, Poly-L-lactic acid: a temporary filler for soft tissue augmentation. J Drugs Dermatol. 2004; 3:385-389. [PubMed]
54. Sherman RN, Sculptra: the new three-dimensional filler. Clin Plast Surg. 2006; 33:539-550. [PubMed]
55. Lowe NJ, Optimizing poly-l-lactic acid use. J Cosmet Laser Ther. 2008; 10:43-46. [PubMed]
56. Vleggaar D, Bauer U, Facial enhancement and the European experience with Sculptra (poly-l-lactic acid). J Drugs Dermatol. 2004; 3:542-547. [PubMed]
57. Lam SM, Azizzadeh B, Graivier M, Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring. Plast Reconstr Surg. 2006; 118:55S-63S. [PubMed] (Pubitemid 44319091)
58. Gladstone HB, Cohen JL, Adverse effects when injecting facial fillers. Semin Cutan Med Surg. 2007; 26:34-39. [PubMed]
59. Andre P, Lowe NJ, Parc A et al., Adverse reactions to dermal fillers: a review of European experiences. J Cosmet Laser Ther. 2005; 7:171-176. [PubMed] (Pubitemid 43111918)
60. Carruthers JD, Carruthers A, Facial sculpting and tissue augmentation. Dermatol Surg. 2005; 31:1604-1612. [PubMed]
61. Christensen L, Breiting V, Janssen M et al., Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg. 2005; 29:34-48. [PubMed] (Pubitemid 40685159)
62. Narins RS, Jewell M, Rubin M et al., Clinical conference: management of rare events following dermal fillers--focal necrosis and angry red bumps. Dermatol Surg. 2006; 32:426-434. [PubMed]
63. Tzikas TL, Evaluation of the Radiance FN soft tissue filler for facial soft tissue augmentation. Arch Facial Plast Surg. 2004; 6:234-239. [PubMed]
64. Alam M, Yoo SS, Technique for calcium hydroxylapatite injection for correction of nasolabial fold depressions. Dermatol Surg. 2007; 56:285-289. [PubMed] (Pubitemid 46074253)
65. Jansen DA, Graivier MH, Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation. Plast Reconstr Surg. 2006; 118:22S-30S, discussion. [PubMed]
66. Baumann LS, Shamban AT, Lupo MP et al., Comparison of Smooth-Gel Hyaluronic Acid Dermal Fillers with Cross-linked Bovine Collagen: A Multicenter, Double-Masked, Randomized, Within-Subject Study. Dermatol Surg. 2007; 33:S128-S135.
67. Moyle GJ, Brown S, Lysakova L et al., Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy. HIV Med. 2006; 7:181-185. [PubMed] (Pubitemid 43337597)
68. Mest DR, Humble G, Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience. Dermatol Surg. 2006; 32:1336-1345. [PubMed] (Pubitemid 44691136)
69. Lemperle G, Rullan PP, Gauthier-Hazan N, Avoiding and treating dermal filler complications. Plast Reconstr Surg. 2006; 118:92S-107S. [PubMed] (Pubitemid 44319095)
70. Duffy DM, Complications of fillers: overview. Dermatol Surg. 2005; 31:1626-1633. [PubMed]
71. Guaraldi G, Orlando G, De FD et al., Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study. Antivir Ther. 2005; 10:753-759. [PubMed] (Pubitemid 41376855)
72. Onesti MG, Renzi LF, Paoletti F et al., Use of polylactic acid in face lipodystrophy in HIV positive patients undergoing treatment with antiretroviral drugs (HAART). Acta Chir Plast. 2004; 46:12- (Pubitemid 38735908)
73. Moyle GJ, Lysakova L, Brown S et al., A randomized openlabel study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med. 2004; 5:82-87. [PubMed] (Pubitemid 38404660)
74. Burgess CM, Quiroga RM, Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol. 2005; 52:233-239. [PubMed]
75. Hanke CW, Redbord KP, Safety and efficacy of poly-L-lactic acid in HIV lipoatrophy and lipoatrophy of aging. J Drugs Dermatol. 2007; 6:123-128. [PubMed]
76. Mest DR, Humble GM, Retreatment with Injectable Poly-l- Lactic Acid for HIV-Associated Facial Lipoatrophy: 24-Month Extension of the Blue Pacific Study. Dermatol Surg. 2009; 35:350-359.
77. Roy D, Sadick N, Mangat D, Clinical trial of a novel filler material for soft tissue augmentation of the face containing synthetic calcium hydroxylapatite microspheres. Dermatol Surg. 2006; 32:1134-1139. [PubMed] (Pubitemid 44370117)
78. Sadick NS, Katz BE, Roy D, A Multicenter, 47-Month Study of Safety and Efficacy of Calcium Hydroxylapatite for Soft Tissue Augmentation of Nasolabial Folds and Other Areas of the Face. Dermatol Surg. 2007; 33:S122-S127. (Pubitemid 350233448)
79. Bugge H, Negaard A, Skeie L et al., Hyaluronic acid treatment of facial fat atrophy in HIV-positive patients. HIV Med. 2007; 8:475-482. [PubMed] (Pubitemid 47616825)
80. Carruthers A, Carey W, De Lorenzi C et al., Randomized, double-blind comparison of the efficacy of two hyaluronic acid derivatives, restylane perlane and hylaform, in the treatment of nasolabial folds. Dermatol Surg. 2005; 31:1591-1598. [PubMed]
81. Jacovella PF, Calcium hydroxylapatite facial filler (Radiesse): indications, technique, and results. Clin Plast Surg. 2006; 33:511-523. [PubMed]
82. Narins RS, Minimizing adverse events associated with poly-Llactic acid injection. Dermatol Surg. 2008; 34 Suppl 1:S100-S104. [PubMed]
83. Lowe NJ, Dispelling the myth: appropriate use of poly-L-lactic acid and clinical considerations. J Eur Acad Dermatol Venereol. 2006; 20:2-6. [PubMed]
84. Vleggaar D, Poly-L-lactic acid: consultation on the injection techniques. J Eur Acad Dermatol Venereol. 2006; 20:17-21. [PubMed]
85. Alam M, Gladstone H, Kramer EM et al., ASDS guidelines of care: injectable fillers. Dermatol Surg. 2008; 34 Suppl 1:S115-S148. [PubMed]
86. Coleman SR, Avoidance of arterial occlusion from injection of soft tissue fillers. Aesthetic Surg J. 2002; 22:555-557.
87. American Society for Aesthetic Plastic Surgery. Cosmetic surgery national data bank statistics. 2008.